RGPEO Geriatric Rounds
The RGPEO is committed to enhancing geriatric care through education, collaboration, and innovation.
Regional Rounds offer health professional working with older adults – including physicians, nurses, primary care provider, allied health professionals, and others – with updates on best practices, initiatives, and latest findings. These sessions held at The Ottawa Hospital Civic Campus Amphitheatre and are also broadcast virtually across the region, feature a 45-minute presentation followed by a 15 minute Q&A.
The Regional Geriatric Rounds are held monthly in the Amphitheatre of the Ottawa Hospital, Civic Campus, 1053 Carling Avenue from 12:00 PM to 1:00 PM, unless otherwise specified. They are now offered in a hybrid format, allowing participants to attend in person or virtually via Teams. All those interested in the care of the elderly are invited to attend.
Speaker
Regional Geriatric Rounds: Unseen and Undervalued: Identifying Elder Abuse, Risk and Barriers in Healthcare
- Date: October 15, 2025
- Time: 12:00 PM to 1:00 PM
Unseen and Undervalued: Identifying Elder Abuse, Risk and Barriers in Healthcare
This session will provide a concise yet comprehensive overview of elder abuse, including its definitions, prevalence, and devastating consequences. Participants will explore methods of identifying elder abuse and examine evidence-based approaches to assessing risk for ongoing harm. The session will conclude by addressing barriers healthcare professionals face in recognizing, reporting, and managing this increasingly prevalent issue.
Learning Objectives:
- Gain insight into the scope and impact of elder abuse.
- Explore practical tools and approaches for identifying elder abuse and assessing the risk of ongoing harm.
- Examine barriers and considerations that you can take forward to strengthen your practice as a health care professional.
Speaker
Regional Geriatric Rounds: Anti-Amyloid Therapies in Alzheimer’s Disease
- Date: November 19, 2025
- Time: 12:00 PM to 1:00 PM
Anti-Amyloid Therapies in Alzheimer’s Disease
This presentation will discuss efficacy and safety data surrounding anti-amyloid therapies, a new class of treatment for Alzheimer’s disease. In addition, logistical considerations for administering anti-amyloid therapies will also be discussed, in a Canadian context.”
Learning Objectives:
- Understand the potential risks and benefits of anti-amyloid therapies for Alzheimer’s disease.
- Understand the logistics of administering anti-amyloid therapies in Canada.
Note: This session will be hosted out of the Elisabeth Bruyere Hospital Auditorium.
